MEF2C TRANSCRIPTION FACTOR IS ASSOCIATED WITH THE GENETIC AND EPIGENETIC RISK ARCHITECTURE OF SCHIZOPHRENIA AND IMPROVES COGNITION IN MICE

Large scale consortia mapping the genomic risk architectures of schizophrenia provide vast amounts of molecular information, with largely unexplored therapeutic potential. We harnessed publically available information from the Psychiatric Genomics Consortium, and report MYOCYTE ENHANCER FACTOR 2C (M...

Descripción completa

Detalles Bibliográficos
Autores principales: Mitchell, Amanda C., Javidfar, Behnam, Pothula, Venu, Ibi, Daisuke, Shen, Erica Y., Peter, Cyril J., Bicks, Lucy, Fehr, Tristan, Jiang, Yan, Brennand, Kristen J., Neve, Rachael L., Gonzalez-Maeso, Javier, Akbarian, Schahram
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5966823/
https://www.ncbi.nlm.nih.gov/pubmed/28115742
http://dx.doi.org/10.1038/mp.2016.254

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5966823/
https://www.ncbi.nlm.nih.gov/pubmed/28115742
http://dx.doi.org/10.1038/mp.2016.254

Ejemplares similares